Mid-and long-term follow up of endovascular aortic repair for infrarenal abdominal aortic aneurysms with diabetes mellitus
10.3760/cma.j.issn.1007-631X.2018.06.009
- VernacularTitle:腔内修复术治疗肾下型腹主动脉瘤合并糖尿病的中远期疗效观察
- Author:
Guoyi SUN
1
;
Jie LIU
;
Xin JIA
;
Senhao JIA
;
Minhong ZHANG
;
Yongle XU
;
Hongpeng ZHANG
;
Xiaohui MA
;
Jiang XIONG
;
Xiaoping LIU
;
Wei GUO
Author Information
1. 解放军总医院血管外科
- Keywords:
Aortic aneurysms,abdominal;
Stents;
Diabetes mellitus;
Treatment outcome
- From:
Chinese Journal of General Surgery
2018;33(6):470-472
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the outcome of the endovascular aortic repair (EVAR) of abdominal aortic aneurysms (AAA) with diabetes mellitus (DM) and analyze the factors that influence its mid-long-term curative effect.Methods From Jan 2004 to Jun 2014,follow-up data of 103 AAA patients with DM treated with EVAR was analyzed retrospectively.Results Effective follow-up visits were conducted on 88 patients (85.43%).The patients were tracked for an median of 3.59 years,with the longest follow-up 10.32 years.25 deaths occurred and the all-cause mortality rate was 24.3%.6 cases had intervention-related complications (5.8%),including endoleaks,thrombosis,embolism,infection,false aneurysms.2 secondary interventions were conducted on 2 patients.The five-year cumulative survival rate was 70% and the ten-year cumulative survival rate was 61%.Conclusion EVAR is safe for AAA patients with DM.